Trial Details
COMPLETEDBasic Information
| Clinical ID | c4437 |
|---|---|
| Identifier | NCT00528073 |
| Trial Title | Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Rifaximin-EIR |
Participant Information
| Sponsor | Alfasigma S.p.A. |
|---|---|
| City | Amiens |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2007-09 |
|---|---|
| Primary Completion Date | 2009-03 |
| Completion Date | 2009-10 |